← The SEC Ephemeris: the whole map
Innocoll Pharmaceuticals bupivacaine hydrochloride collagen-matrix implants
In the graph: all 1 documents (3 pages).
- Application
- NDA 209511
- Ticker
- Innocoll Pharmaceuticals
- Product
- bupivacaine hydrochloride collagen-matrix implants
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- November 30, 2018
From FDA letters and SEC filings. Not investment or medical advice.